Denelle J. Waynick

A member of the Zogenix board of directors since September 2020, Ms. Waynick has more than 25 years of experience as a legal and strategic advisor across multiple sectors, including the biopharmaceutical industry. She currently serves as General Counsel and Corporate Secretary of MyoKardia. Previously, she served as Vice President, Legal Affairs (U.S.), U.S. General Counsel & Head of Global Enterprise Risk Management at UCB. During her tenure at UCB, Ms. Waynick relocated to UCB’s headquarters in Belgium for a year, where she provided counsel to the global business units, including commercial operations, R&D, and the regulatory team. Prior to UCB, Ms. Waynick oversaw legal operations as Vice President, Legal Affairs, Global Brands at Actavis, Inc. (now AbbVie) and as Legal Director at Schering-Plough (now Merck). In addition to her roles as in-house counsel, Ms. Waynick was Chief of Staff for the Office of the New Jersey Attorney General.

Ms. Waynick serves on the Board of the Atlanta Volunteer Lawyers Foundation. She holds a Juris Doctor degree from Howard University School of Law and a Bachelor of Science in Accounting from Rutgers, The State University of New Jersey, Newark.